Seattle biotech firm shares revenue with Indigenous people who donate genetic info

Genetic material is deeply personal, and powerful. Now, Seattle-based Variant Bio has a plan to develop drugs for metabolic disorders, using data collected from Indigenous populations. In exchange, they’re offering financial benefits and revenue sharing. We'll hear from company's Director of Ethics and Engagement and University of Washington School of Medicine bioethicist Susan Brown Trinidad. You can watch the Seattle School Board meeting here. You can watch state lawmakers talk about education funding here. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at [email protected], leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.